Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mixed lineage leukemia translocations and a leukemia stem cell program.

Joerg Faber1, Scott A Armstrong

  • 1Division of Hematology/Oncology, Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Cancer Research
|September 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

Blood·2026
Same author

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

Nature communications·2026
Same author

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

Blood advances·2026
Same author

Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells.

Cell·2026
Same author

Feasibility and Validity of the 6-Minute Cycling Test in Childhood Cancer Patients.

Pediatric hematology and oncology·2026
Same author

Exploring User Experiences of an Augmented Reality Smartphone App Prescribing Exercise for Children and Young People With Cancer: Results From a Qualitative Study.

JMIR formative research·2026

Cancer stem cells (CSCs) may originate from normal stem cells or differentiated progenitors. Our research shows oncoproteins can transform progenitors into leukemia stem cells, offering new therapeutic strategies against tumor self-renewal.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Hematopoiesis

Background:

  • Cancer stem cells (CSCs) are crucial for tumor self-renewal and progression.
  • The origin of CSCs is debated: they may arise from normal stem cells or more differentiated progenitors.
  • Understanding CSC origins is key to developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the potential of differentiated progenitor cells to give rise to cancer stem cells.
  • To explore the role of mixed lineage leukemia fusion oncoproteins in CSC formation.
  • To identify novel therapeutic strategies targeting tumor self-renewal mechanisms.

Main Methods:

  • Utilized mixed lineage leukemia fusion oncoproteins in a hematopoietic progenitor model.
  • Analyzed the resulting leukemias for the presence and characteristics of leukemia stem cells.

Related Experiment Videos

  • Assessed the self-renewal associated gene expression programs in the generated leukemia stem cells.

    • Main Results:

    • Mixed lineage leukemia fusion oncoproteins successfully converted committed hematopoietic progenitors into leukemias.
    • These induced leukemias contained leukemia stem cells.
    • Leukemia stem cells expressed a self-renewal program within a differentiated myeloid cell context.

    Conclusions:

    • Differentiated progenitor cells can be a source of cancer stem cells.
    • Mixed lineage leukemia fusion oncoproteins provide a mechanism for CSC generation from progenitors.
    • These findings offer insights into CSC pathobiology and suggest strategies to target tumor self-renewal.